Amphastar Pharmaceuticals, Inc.

NASDAQ:AMPH

Drug Manufacturers - Specialty & Generic

Healthcare
$29.71 -1.60%

-$0.31 today

Market cap
$1.27B
Beta
0.90
P/E (TTM)
10.9
EPS (TTM)
$1.75
52W Low $16.65High $31.26

Volume 0.53M

Average 0.59M

AMPH Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Amphastar Pharmaceuticals, Inc.NASDAQ: AMPH

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) declines year over year

Q1 FY2026 weighted avg shares (diluted) of 46.46M shares fell 6.9% year over year, ahead of the -8.0% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it fell 1.5% from the prior quarter. Over 3 fiscal years it compounded at -2.8% a year.

Context

  • Weighted avg shares (diluted) increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -6.9% holds above the trailing-twelve-month pace of -8.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
46.46M-1.5% QoQ
Last fiscal yearDec 2025
48.22M-7.4% YoY
LTMMar 2026
47.36M-8.0% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-6.9%——
1 year-7.4%——
3-year CAGR-2.8%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
48.22M USD
Year-over-year change
-7.4%
4-year CAGR
-0.8%

Weighted Avg Shares (Diluted) vs competitors

How AMPH compares with its peers on the latest reported figures

  • AMPH's LTM Mar 2026 weighted avg shares (diluted) of 47.36M shares is the 6th highest of the 8 companies compared; the peer median is 374.23M shares.
  • Its year-over-year change of -8.0% is the lowest of 8, against a peer median of +2.4%.
  • Over three fiscal years its annual growth of -2.8% compares with a peer median of +1.9%.
AMPH Competitors Peer median
Weighted Avg Shares (Diluted) for AMPH and competitors
Company Period LTM YoY 3-year CAGR
TEVATeva Pharmaceutical Industries LimitedLTM Jun 20261.17B +2.4%+1.9%
VTRSViatris Inc.LTM Jun 20261.16B -2.2%-1.3%
RDYDr. Reddy's Laboratories LimitedLTM Sep 2026833.5M -0.0%+0.1%
BHCBausch Health Companies Inc.LTM Jun 2026374.23M +0.9%+1.2%
AMRXAmneal Pharmaceuticals, Inc.LTM Jun 2026326.65M +3.2%+29.1%
AMPHAmphastar Pharmaceuticals, Inc.LTM Mar 202647.36M -8.0%-2.8%
COLLCollegium Pharmaceutical, Inc.LTM Mar 202639.57M +3.1%+5.5%
ETONEton Pharmaceuticals, Inc.LTM Mar 202628.06M +6.5%+2.3%
Peer median (excluding AMPH) 374.23M+2.4%+1.9%

Competitors are the stored peer set for AMPH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue437.77M498.99M644.4M731.97M719.89M
Cost of Revenue238.03M250.13M293.27M358.11M363.83M
Gross Profit199.74M248.86M351.12M373.86M356.06M
Gross Margin45.6%49.9%54.5%51.1%49.5%
Research & Development60.93M74.77M73.74M73.91M85.84M
Selling, General & Admin68.92M66.59M80.39M94.52M129.81M
Operating Expenses129.85M141.36M154.13M168.44M215.65M
Depreciation & Amortization26.53M28.28M41.78M57.21M63.2M
EBITDA111.56M146.16M240.29M277.31M212.31M
EBITDA Margin25.5%29.3%37.3%37.9%29.5%
Operating Income69.89M107.5M196.99M205.42M140.4M
Operating Margin16.0%21.5%30.6%28.1%19.5%
Interest Income601K1.32M5.46M10.61M8.68M
Interest Expense885K1.85M27.16M30.34M25.48M
Other Income / Expenses14.04M7.37M(27.61M)(16.23M)(16.78M)
Income Before Tax83.93M114.86M169.38M189.19M123.62M
Pre-Tax Margin19.2%23.0%26.3%25.8%17.2%
Income Tax Expense20.63M23.48M31.83M29.67M25.53M
Net Income62.12M91.39M137.55M159.52M98.09M
Net Margin14.2%18.3%21.3%21.8%13.6%
EPS (Basic)1.301.882.853.292.10
EPS (Diluted)1.251.742.603.062.03
Weighted Avg Shares47.78M48.55M48.27M48.43M46.74M
Weighted Avg Shares (Diluted)49.78M52.43M53M52.06M48.22M

Amphastar Pharmaceuticals, Inc.

NASDAQ:AMPH

Intrinsic Alpha fair value

Locked

Current Price

$29.71

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.